Search
for
Sort by
Research 121–150 of 1000+
- In Vitro Percutaneous Permeation and Skin Accumulation of Finasteride Using Vesicular Ethosomal Carriers
- Persistent Sexual, Emotional, and Cognitive Impairment Post-Finasteride
- Exogenous Testosterone Alone or With Finasteride Does Not Improve Measurements of Cognition in Healthy Older Men With Low Serum Testosterone
- Comparison of finasteride versus spironolactone in the treatment of idiopathic hirsutism
- Comparison of finasteride versus flutamide in the treatment of hirsutism
- Outcome of long-term treatment with the 5α-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up
- Neuroactive Steroid Levels are Modified in Cerebrospinal Fluid and Plasma of Post‐Finasteride Patients Showing Persistent Sexual Side Effects and Anxious/Depressive Symptomatology
- Comparison of Finasteride (Proscar®) and Serenoa repens (Permixon®) in the Inhibition of 5-Alpha Reductase in Healthy Male Volunteers
- The Effect of 5α-Reductase Inhibition With Dutasteride and Finasteride on Bone Mineral Density, Serum Lipoproteins, Hemoglobin, Prostate Specific Antigen and Sexual Function in Healthy Young Men
- Finasteride Treatment of Patterned Hair Loss in Normoandrogenic Postmenopausal Women
- An Open, Randomized, Comparative Study of Oral Finasteride and 5% Topical Minoxidil in Male Androgenetic Alopecia
- Clinical and endocrine effects of finasteride, a 5α-reductase inhibitor, in women with idiopathic hirsutism
- Finasteride: A slow-binding 5.alpha.-reductase inhibitor
- Persistent Sexual Dysfunction and Suicidal Ideation in Young Men Treated with Low-Dose Finasteride: A Pharmacovigilance Study
- Combined Sabal and Urtica extract vs finasteride in BPH (Alken stage I–II)
- Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)
- The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride
- Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): Three- and 4-year results
- Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, daily
- Systematic Review of Platelet-Rich Plasma Use in Androgenetic Alopecia Compared with Minoxidil®, Finasteride®, and Adult Stem Cell-Based Therapy
- The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia
- Effects of finasteride in patients with inflammatory chronic pelvic pain syndrome: a double-blind, placebo-controlled, pilot study
- Finasteride Blocks the Reduction in Ictal Activity Produced by Exogenous Estrous Cyclicity
- 5 mg/day finasteride treatment for normoandrogenic Asian women with female pattern hair loss
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism
- Finasteride for the Treatment of Hidradenitis Suppurativa in Children and Adolescents
- Finasteride in the treatment of alopecia
- Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma
- Studies on Neurosteroids XXV. Influence of a 5.ALPHA.-Reductase Inhibitor, Finasteride, on Rat Brain Neurosteroid Levels and Metabolism